Diagnotes Joins Allscripts Developer Program

Published on:

Indianapolis, Ind. (PRWEB) October 29, 2014 - Diagnotes, Inc., an Indianapolis-based health technology company, today announced that it has joined the Allscripts Developer Program (ADP). The program provides an opportunity for companies to help caregivers improve healthcare and their bottom lines by integrating new innovative software applications and devices with their Allscripts solutions. The Diagnotes® HIPAA-compliant mobile communication software solution streamlines secure communication with added functionality to deliver key patient health information to a clinician’s mobile device when needed. Diagnotes’ five integrated components ensure both continuity of care and revenue cycle management, providing secure texting, provider scheduling, clinical documentation, answering service automation, and electronic health record (EHR) integration. All of the components are available on whatever mobile device the provider prefers – smartphone, tablet or laptop.

“With the ability to customize the Diagnotes software components to coordinate with the individual practice workflow, Diagnotes can provide benefits for any type of medical practice,” Diagnotes Chairman, CEO and Co-founder Dave Wortman said. “We’re looking forward to incorporating this functionality into Allscripts solutions.”

To learn more about Diagnotes and the Allscripts Developer Program, visit the Diagnotes partner page on the Allscripts Application Store.

About Diagnotes

Diagnotes, Inc. is an Indianapolis-based health IT company with a HIPAA-compliant mobile communication system that gives medical groups the tools to improve communication among providers, patients and staff. The Diagnotes system is available on smartphones, tablets and the web and comprises five interlocking components: secure texting, provider scheduling, clinical documentation, answering service automation and EHR integration. By enabling more effective communication, Diagnotes increases revenue, decreases cost, and enhances both provider and patient experience. For more information about Diagnotes, visit http://www.diagnotes.com.

 

Related Content

Pitching the business case for 3D printing labs in radiology
FDA issues first-ever clearance for OTC oximeter
Augmented reality company secures $15M in funding from Cleveland Clinic, Mayo, GE Healthcare and more
Merck to acquire Prometheus Biosciences for $10.8B
Johnson & Johnson scraps RSV vaccine after trial
Intermountain Health launches new biotech company

Around the web

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Cardiovascular Business
Cardiology groups cheer new bill that would improve access to Medicare claims data

If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup